Rescriptor (delavirdine), another antiviral for HIV

    The FDA just approved Rescriptor (delavirdine), another antiviral for HIV...from Pharmacia & Upjohn.

    Rescriptor is a non-nucleoside reverse transcriptase inhibitor (NNRTI)...similar to Viramune (nevirapine).

    These drugs inhibit reverse transcriptase...the same enzyme that is inhibited by AZT.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote